<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="29832" whole_study_id="29832" phs="001666" v="1" p="1" createDate="2018-05-28T20:20:43-05:00" completedByGPADate="2018-06-01T17:06:35-05:00" modDate="2020-07-27T09:46:43-05:00" maxParentChildStudyModDate="2020-07-27T09:46:43-05:00" handle="Alisertib_PC" num_participants="60"><StudyInfo accession="phs001666.v1.p1" parentAccession="phs001666.v1.p1"><BioProject id="PRJNA486061" entrez_id="486061" type="bp_admin_access"/><BioProject id="PRJNA486062" entrez_id="486062" type="bp_data_submission"/><StudyNameEntrez>A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="Yes"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="tumor_normal"/><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>supporting_documents</StudyType><StudyType>tumor_normal</StudyType><StudyType>dna</StudyType><StudyType>rna</StudyType><StudyType>whole_exome</StudyType><StudyType>whole_transcriptome</StudyType></StudyTypes><Funding>P50CA211024</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="HIBELTRAN" aid="2" auth="eRA" login="HIBELTRAN" fname="Himisha" mname="" lname="Beltran" email="himisha_beltran@dfci.harvard.edu"><Role allow_direct_access="true">PI</Role><Organization>WEILL MEDICAL COLL OF CORNELL UNIVDANA-FARBER CANCER INST</Organization></Person><Person nedid="0011054091" aid="1" auth="cit" login="jarnold" fname="Julia" mname="T" lname="Arnold" email="jarnold@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014159529" aid="1" auth="cit" login="waltont" fname="Tamara" mname="Bene" lname="Walton" email="waltont@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This whole exome sequencing (WES) and RNA sequencing (RNA-seq) data was generated at Weill Cornell Medicine from patients enrolled in this multicenter phase 2 clinical trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer. The origin of the dataset is described in detail in a manuscript currently in revision.  We acknowledge support from the Prostate Cancer Foundation and the NIH (NCI P50-CA211024).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="3074" CGType="cg_class_HMB" title="Health/Medical/Biomedical (PUB)" name="HMB-PUB" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor agrees to make results of studies using the data available to the larger scientific community.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>